Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Kensey Nash Corporation (NASDAQ: KNSY), a medical device company primarily focused on regenerative medicine for a wide range of medical procedures,...
Kensey Nash Corporation (Nasdaq: KNSY), today announced that it has entered into a definitive agreement with Royal DSM (DSM) (NYSE Euronext: DSM...
Kensey Nash Corporation (Nasdaq: KNSY) today announced that it will release its earnings results for its third quarter ended March 31, 2012 at 7:00 A....
Kensey Nash Corporation (Nasdaq: KNSY), a leading medical technology company that provides innovative resorbable biomaterial technology for a wide...
Kensey Nash Corporation (NASDAQ: KNSY) today announced that the Company has entered into a settlement agreement with St. Jude Medical which resolves...
The board of directors of Kensey Nash Corporation (Nasdaq: KNSY) announced today that the board has declared a cash dividend of $0.25 per share of...
Kensey Nash Corporation (Nasdaq: KNSY) is scheduled to present at the Sidoti & Company Sixteenth Annual New York Institutional Investor Forum on...
Kensey Nash Corporation (Nasdaq: KNSY) is scheduled to present at the Canaccord Genuity Musculoskeletal Conference held on Tuesday, February 7, 2012...
Kensey Nash Corporation (Nasdaq: KNSY) today announced that it will release its earnings results for its second quarter ended December 31, 2011 at...
Kensey Nash Corporation (NASDAQ: KNSY) today announced that it has agreed with St. Jude Medical to enter into non-binding mediation in an attempt to...
Kensey Nash Corporation (Nasdaq: KNSY) today announced that it was recently informed by Spectranetics Corporation (Nasdaq: SPNC) that they reached a...
Kensey Nash Corporation (Nasdaq: KNSY) today announced that it received a Small Business Innovation Research (SBIR) grant from the National...
Kensey Nash Corporation (Nasdaq: KNSY) is scheduled to present at the following investor conferences in November. Douglas G. Evans, Kensey Nash's...
Kensey Nash Corporation (Nasdaq: KNSY) today announced that it will release its earnings results for its first quarter ended September 30, 2011 at...
Kensey Nash Corporation (Nasdaq: KNSY) is scheduled to present at the Jefferies Global Healthcare Conference in London on Tuesday, September 27th,...
Kensey Nash Corporation (Nasdaq: KNSY) today announced that Lisa Earnhardt, President and Chief Executive Officer of Intersect ENT, has joined Kensey ...
Kensey Nash Corporation (Nasdaq: KNSY) is scheduled to present at the following investor conferences in September. Kensey Nash will be participating...
Kensey Nash Corporation (Nasdaq: KNSY) is scheduled to present at the Jefferies 2011 Global Healthcare Conference at The Grand Hyatt in New York, on...
Kensey Nash Corporation (Nasdaq: KNSY) announced today that it has entered into a new $35 million unsecured revolving credit facility with Wells...
Kensey Nash Corporation (NASDAQ: KNSY), today announced it has acquired the assets comprising the product lines of Synthes Inc.'s (SIX: SYST.VX)...
Kensey Nash Corporation (Nasdaq: KNSY) is scheduled to present at two investor conferences in May. Joseph W. Kaufmann, Kensey Nash's President and...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.